NCT05441475 2026-02-25A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC PatientsAbbisko Therapeutics Co, LtdPhase 2 Enrolling by invitation118 enrolled
NCT06882876 2025-09-19JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib StudyXiangya Hospital of Central South UniversityPhase 1 Enrolling by invitation20 enrolled